Merck’s Keytruda may be the most talked about drug facing loss of exclusivity but it’s far from the only one, as several of ...

Trump has long railed against what he calls the unfair treatment of US automotive exports in foreign markets and has vowed to ...

President Donald Trump said on Tuesday that he plans to impose tariffs of around 25% on auto imports as well as ...

Has Irish government considered what effect going to Washington on St Patrick’s Day might have on EU colleagues amid a ...

Dutch healthcare technology company Philips forecast a growth of 1% to 3% in 2025 comparable sales on Wednesday after missing ...

The results were stunning. So too was the nationality of the company behind them. Akeso, a biotech firm, is Chinese.

India's GlaxoSmithKline Pharmaceuticals reported a higher adjusted third-quarter profit on Friday, led by sustained demand ...

In this process, royalty recipients often face the issue where multiple small future royalty streams cannot fulfill ongoing large lump-sum R&D funding needs. The mismatch is where Royalty Pharma ...

The Trump administration's decision to pause enforcement of an anti-bribery law raised the specter that drugmakers could ...